Literature DB >> 28741531

Molecular Discriminators of Racial Disparities in Prostate Cancer.

Bushra Ateeq1, Vipul Bhatia2, Sakshi Goel2.   

Abstract

Recent molecular characterization of prostate cancer (PCa) identified novel genetic aberrations and disease subtypes. The frequencies of molecular aberrations show racial disparity. Clinical strategies and targeted therapies embracing these racial differences are required. Here we discuss ethnic differences in genetic alterations and their impact on the susceptibility, progression, and treatment of prostate cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  8q24 locus; SPINK1; SPOP; TMPRSS2–ERG; prostate cancer

Mesh：

Substances：

Year:  2016        PMID： 28741531      PMCID： PMC6485634          DOI： 10.1016/j.trecan.2016.01.005

Source DB:  PubMed          Journal:  Trends Cancer        ISSN： 2405-8025


  14 in total

1.  8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.

Authors:  Nasim Ahmadiyeh; Mark M Pomerantz; Chiara Grisanzio; Paula Herman; Li Jia; Vanessa Almendro; Housheng Hansen He; Myles Brown; X Shirley Liu; Matt Davis; Jennifer L Caswell; Christine A Beckwith; Adam Hills; Laura Macconaill; Gerhard A Coetzee; Meredith M Regan; Matthew L Freedman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-07       Impact factor: 11.205

2.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Authors:  Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

3.  A common variant associated with prostate cancer in European and African populations.

Authors:  Laufey T Amundadottir; Patrick Sulem; Julius Gudmundsson; Agnar Helgason; Adam Baker; Bjarni A Agnarsson; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Jean-Baptiste Cazier; Jesus Sainz; Margret Jakobsdottir; Jelena Kostic; Droplaug N Magnusdottir; Shyamali Ghosh; Kari Agnarsson; Birgitta Birgisdottir; Louise Le Roux; Adalheidur Olafsdottir; Thorarinn Blondal; Margret Andresdottir; Olafia Svandis Gretarsdottir; Jon T Bergthorsson; Daniel Gudbjartsson; Arnaldur Gylfason; Gudmar Thorleifsson; Andrei Manolescu; Kristleifur Kristjansson; Gudmundur Geirsson; Helgi Isaksson; Julie Douglas; Jan-Erik Johansson; Katarina Bälter; Fredrik Wiklund; James E Montie; Xiaoying Yu; Brian K Suarez; Carole Ober; Kathleen A Cooney; Henrik Gronberg; William J Catalona; Gudmundur V Einarsson; Rosa B Barkardottir; Jeffrey R Gulcher; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2006-05-07       Impact factor: 38.330

4.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.

Authors:  Matthew L Freedman; Christopher A Haiman; Nick Patterson; Gavin J McDonald; Arti Tandon; Alicja Waliszewska; Kathryn Penney; Robert G Steen; Kristin Ardlie; Esther M John; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

5.  TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.

Authors:  Cristina Magi-Galluzzi; Toyonori Tsusuki; Paul Elson; Kelly Simmerman; Chris LaFargue; Raquel Esgueva; Eric Klein; Mark A Rubin; Ming Zhou
Journal:  Prostate       Date:  2010-09-28       Impact factor: 4.104

6.  Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.

Authors:  Christopher E Barbieri; Sylvan C Baca; Michael S Lawrence; Francesca Demichelis; Mirjam Blattner; Jean-Philippe Theurillat; Thomas A White; Petar Stojanov; Eliezer Van Allen; Nicolas Stransky; Elizabeth Nickerson; Sung-Suk Chae; Gunther Boysen; Daniel Auclair; Robert C Onofrio; Kyung Park; Naoki Kitabayashi; Theresa Y MacDonald; Karen Sheikh; Terry Vuong; Candace Guiducci; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Gordon Saksena; Douglas Voet; Wasay M Hussain; Alex H Ramos; Wendy Winckler; Michelle C Redman; Kristin Ardlie; Ashutosh K Tewari; Juan Miguel Mosquera; Niels Rupp; Peter J Wild; Holger Moch; Colm Morrissey; Peter S Nelson; Philip W Kantoff; Stacey B Gabriel; Todd R Golub; Matthew Meyerson; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nat Genet       Date:  2012-05-20       Impact factor: 38.330

7.  Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

Authors:  Nuria Coll Bastus; Lara K Boyd; Xueying Mao; Elzbieta Stankiewicz; Sakunthala C Kudahetti; R Tim D Oliver; Daniel M Berney; Yong-Jie Lu
Journal:  Cancer Res       Date:  2010-10-14       Impact factor: 12.701

8.  Induced chromosomal proximity and gene fusions in prostate cancer.

Authors:  Ram-Shankar Mani; Scott A Tomlins; Kaitlin Callahan; Aparna Ghosh; Mukesh K Nyati; Sooryanarayana Varambally; Nallasivam Palanisamy; Arul M Chinnaiyan
Journal:  Science       Date:  2009-10-29       Impact factor: 47.728

Review 9.  Prostate cancer in Asian men.

Authors:  Kazuto Ito
Journal:  Nat Rev Urol       Date:  2014-03-04       Impact factor: 14.432

10.  Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.

Authors:  Philip Rosen; David Pfister; Denise Young; Gyorgy Petrovics; Yongmei Chen; Jennifer Cullen; Diana Böhm; Sven Perner; Albert Dobi; David G McLeod; Isabell A Sesterhenn; Shiv Srivastava
Journal:  Urology       Date:  2012-08-28       Impact factor: 2.649
View more
  6 in total

Review 1.  TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences.

Authors:  Cindy Ke Zhou; Denise Young; Edward D Yeboah; Sally B Coburn; Yao Tettey; Richard B Biritwum; Andrew A Adjei; Evelyn Tay; Shelley Niwa; Ann Truelove; Judith Welsh; James E Mensah; Robert N Hoover; Isabell A Sesterhenn; Ann W Hsing; Shiv Srivastava; Michael B Cook
Journal:  Am J Epidemiol       Date:  2017-12-15       Impact factor: 4.897

Review 2.  The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer.

Authors:  Ealia Khosh Kish; Muhammad Choudhry; Yaser Gamallat; Sabrina Marsha Buharideen; Dhananjaya D; Tarek A Bismar
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer.

Authors:  Vipul Bhatia; Anjali Yadav; Ritika Tiwari; Shivansh Nigam; Sakshi Goel; Shannon Carskadon; Nilesh Gupta; Apul Goel; Nallasivam Palanisamy; Bushra Ateeq
Journal:  Clin Cancer Res       Date:  2018-12-26       Impact factor: 12.531

Review 4.  Insights into disparities observed with COVID-19.

Authors:  J M Carethers
Journal:  J Intern Med       Date:  2020-12-06       Impact factor: 13.068

5.  TP53 alterations of hormone-naïve prostate cancer in the Chinese population.

Authors:  Zhengfang Liu; Hu Guo; Yaofeng Zhu; Yangyang Xia; Jianfeng Cui; Kai Shi; Yidong Fan; Benkang Shi; Shouzhen Chen
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-11-19       Impact factor: 5.554

6.  Comprehensive signature analysis of drug metabolism differences in the White, Black and Asian prostate cancer patients.

Authors:  Yang Liu; Jia-Wei Zhou; Cun-Dong Liu; Jian-Kun Yang; De-Ying Liao; Zhi-Jian Liang; Xiao Xie; Qi-Zhao Zhou; Kang-Yi Xue; Wen-Bing Guo; Ming Xia; Jun-Hao Zhou; Ji-Ming Bao; Cheng Yang; Hai-Feng Duan; Hong-Yi Wang; Zhi-Peng Huang; Shan-Chao Zhao; Ming-Kun Chen
Journal:  Aging (Albany NY)       Date:  2021-06-18       Impact factor: 5.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.